Aeglea BioTherapeutics, Inc.

Q3 2023 13F Holders

Symbol
SYRE
CUSIP
00773J202
Type
Equity
Class
COM NEW
Num filings
30
Total reported value, excl. options
$39.9 M
Manager Report Date Value ($000) Shares Option Type